← All organizations

Nazarbayev University Medical Center

Academic/Hospital

Also known as: Nazarbayev University | Nazarbayev University Medical Center | philip.lafleur@nu.edu.kz

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 18, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (14 distinct, 7 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

ropivacaine

Phase 2 (6 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

nicotine

Other trials (4 own, 0 via acquisition)

Recent trials (11)

NCT07303556Lead sponsorN/ADec 18, 2024
NCT06410352CollaboratorPhase 4Mar 1, 2023
NCT05721872Lead sponsorPhase 1/Phase 2Feb 15, 2023
NCT05484505Lead sponsorEarly Phase 1Nov 1, 2022
NCT05484505Reponsible party - principal investigatorEarly Phase 1Nov 1, 2022
NCT04702685Overall official - principal investigatorPhase 3Jan 31, 2021
NCT04702685Lead sponsorPhase 3Jan 31, 2021
NCT03657836Reponsible party - principal investigatorN/AAug 1, 2018
NCT03657836Lead sponsorN/AAug 1, 2018
NCT03594877Reponsible party - principal investigatorN/AApr 1, 2018
NCT03594877Lead sponsorN/AApr 1, 2018

Details

Last known activity: Dec 18, 2024